Proceedings of the Ninth International Conference of Drug Regulatory Authorities (ICDRA) - Berlin, Germany 25-29 April 1999
(1999; 102 pages) Voir le document au format PDF
Table des matières
Ouvrir ce répertoire et afficher son contenuOpening Ceremony
Ouvrir ce répertoire et afficher son contenuGood regulatory practice
Ouvrir ce répertoire et afficher son contenuGood certification practice
Fermer ce répertoireCounterfeit drugs: challenges and solutions
Afficher le documentIllicit pharmaceutical markets
Afficher le documentThe situation of counterfeit drugs
Afficher le documentRecommendations
Ouvrir ce répertoire et afficher son contenuCurrent issues in regulation and quality
Ouvrir ce répertoire et afficher son contenuInternational Conference on Harmonization: implementation and implications
Ouvrir ce répertoire et afficher son contenuDrug utilization studies
Ouvrir ce répertoire et afficher son contenuInternational Conference on Harmonization and the common technical document
Ouvrir ce répertoire et afficher son contenuKeynote address
Ouvrir ce répertoire et afficher son contenuGlobal and national efforts to reduce tobacco use
Ouvrir ce répertoire et afficher son contenuElectronic communication in the regulatory process
Ouvrir ce répertoire et afficher son contenuTransparency in monitoring the safety of medicines
Ouvrir ce répertoire et afficher son contenuPharmaceutical products for use in special groups
Ouvrir ce répertoire et afficher son contenuNeed for Bioequivalence
Ouvrir ce répertoire et afficher son contenuAntimicrobial resistance: battling the bugs
Ouvrir ce répertoire et afficher son contenuSafety issues of plasma-derived medicinal products
Ouvrir ce répertoire et afficher son contenuHerbal medicines
Ouvrir ce répertoire et afficher son contenuRegulation and access to essential drugs
Afficher le documentParticipants
Afficher le documentBack cover
 

Illicit pharmaceutical markets

Dr Malam Souley, Niger

Until February 1997, date of enactment of the pharmaceutical law, the drug market in Niger was controlled by the National Office for Pharmaceutical Products and Chemicals (ONPPC). This state office enjoyed the monopoly for importation and distribution of drugs, and medical and surgical materials throughout the country.

Confronted with an economic crisis and the devaluation of the local currency, the Government decided to restructure and partially privatize the ONPPC, and three sectors were created:


• The National Office for Pharmaceutical Products and Chemicals (ONPPC).

• The National Laboratory of Public Health and Expertise (LANSPEX).

• The Nigerian Pharmaceutical Industries Company (AONIPHAR).


Within the same pharmaceutical law, two private wholesalers were created to improve availability of medicines. They are the Centralpharm, a limited company, and Copharni, a commercial company.

However, in spite of government efforts to provide drugs of quality, efficacy and sufficient safety at low cost to the population, there has been a proliferation of illicit drugs. The authorities are now elaborating a plan of action based on an analysis of the situation, and a survey of the products on the market in an effort to control this problem.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013